The authors validated the biological relevance of this 2AR-mGlu2 heteromer-mediated signaling in the mouse frontal cortex and demonstrated that the mGlu2-dependent activation of Gq/11 is altered in the frontal cortex from patients with schizophrenia [49]. The gene discussed is GRM2; the disease is schizophrenia.